Cargando…
A case of reversible toxic optic neuropathy from tacrolimus (FK506)
PURPOSE: To report a rare case of reversible vision loss from tacrolimus-associated toxic optic neuropathy. OBSERVATIONS: A 30-year-old man with cystic fibrosis requiring bilateral lung transplantation developed painless, bilateral, gradual onset central vision loss with dyschromatopsia two years af...
Autores principales: | Gokoffski, Kimberly K., Patel, Vivek R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509794/ https://www.ncbi.nlm.nih.gov/pubmed/33005819 http://dx.doi.org/10.1016/j.ajoc.2020.100932 |
Ejemplares similares
-
Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011) -
Advancing Nerve Regeneration: Translational Perspectives of Tacrolimus (FK506)
por: Daeschler, Simeon C., et al.
Publicado: (2023) -
Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis
por: Yang, Zhongbo, et al.
Publicado: (2015) -
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992) -
Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury
por: Yousuf, Seema, et al.
Publicado: (2011)